Diaceutics PLC (AIM:DXRX)
147.56
+1.06 (0.72%)
Sep 4, 2026, 4:08 PM GMT
Diaceutics Revenue
Diaceutics had revenue of 14.56M GBP in the half year ending June 30, 2025, with 46.76% growth. This brings the company's revenue in the last twelve months to 34.40M, up 31.83% year-over-year. In the year 2024, Diaceutics had annual revenue of 32.16M with 35.69% growth.
Revenue (ttm)
34.40M
Revenue Growth
+31.83%
P/S Ratio
3.24
Revenue / Employee
187.50K
Employees
205
Market Cap
124.35M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.16M | 8.46M | 35.69% |
| Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
| Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
| Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
| Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
| Dec 31, 2019 | 13.44M | 3.07M | 29.58% |
| Dec 31, 2018 | 10.37M | 3.00M | 40.74% |
| Dec 31, 2017 | 7.37M | 2.78M | 60.63% |
| Dec 31, 2016 | 4.59M | 3.19M | 228.33% |
| Dec 31, 2015 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Craneware | 157.02M |
| Optima Health | 120.64M |
| Cambridge Cognition Holdings | 9.40M |
| Renalytix | 2.45M |
| Feedback | 849.62K |
| Imaging Biometrics | 810.42K |
| Trellus Health | 262.03K |
Diaceutics News
- 5 weeks ago - Diaceutics Earnings release: H1 2026 - Filings
- 3 months ago - Diaceutics Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - Diaceutics Annual report: H2 2025 - Filings
- 3 months ago - Diaceutics Annual report: H2 2025 - Filings
- 3 months ago - Diaceutics Slides: H2 2025 - Filings
- 3 months ago - Diaceutics Slides: Corporate presentation - Filings
- 3 months ago - Diaceutics PLC (LSE:DXRX) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
- 7 months ago - Diaceutics Earnings release: Q4 2025 - Filings